Bio Green Med Solution (BGMS) Gross Profit (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Gross Profit of $143000.0 for Q1 2026, up 122.84% quarter-over-quarter from -$626000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Gross Profit (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Gross Profit for 5 consecutive years, with $143000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit changed N/A year-over-year to $143000.0; the TTM figure through Mar 2026 stood at -$538000.0 (changed N/A YoY), while the FY2025 annual figure was -$609000.0, changed N/A from the prior year.
- Gross Profit rose to $143000.0 in Q1 2026 per BGMS's latest filing, from -$626000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $143000.0 in Q1 2026 and bottomed at -$626000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79,000.00 |
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | 121,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2012 | -72,000.00 |
| Jun 30, 2012 | -63,000.00 |
| Mar 31, 2012 | 67,000.00 |
| Dec 31, 2011 | 88,000.00 |
| Sep 30, 2011 | 69,000.00 |
| Jun 30, 2011 | 96,000.00 |
| Mar 31, 2011 | 86,000.00 |
| Dec 31, 2010 | -544,000.00 |
| Sep 30, 2010 | 83,000.00 |
| Jun 30, 2010 | 27,000.00 |